MELODY VASQUEZ: Open Payments
NPI 1184257560 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,773 in 143 payments from 20 companies in 2025. Trend: 2023 $2,622 · 2024 $3,148 · 2025 $2,773
Food & beverage: $2,716Education: $57
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $566 |
| UCB, Inc. | 22 | $458 |
| Mallinckrodt Hospital Products Inc. | 20 | $358 |
| Janssen Biotech, Inc. | 10 | $278 |
| Amgen Inc. | 13 | $220 |
| PFIZER INC. | 13 | $216 |
| AstraZeneca Pharmaceuticals LP | 7 | $150 |
| GENZYME CORPORATION | 4 | $81 |
| ANI Pharmaceuticals, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
Products named: Bimzelx, RINVOQ, ACTHAR, TREMFYA, XELJANZ, EVENITY, SAPHNELO, VRAYLAR.
Industry payments across GA — which companies pay providers there.
